Keywords: Actavis, Watson, Financial results, Fourth-quarter and full-year 2012

Lower 4th-qtr 2012 profits at Actavis but beat expectations

Article | 19 February 2013

Print This

US generics major Actavis (NYSE: ACT, the new name for the Watson business) reported net revenue increased 13% to $1.75 billion for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in